跳至主要内容
临床试验/ACTRN12623000864628
ACTRN12623000864628招募中Unknown

Impact of Total Arterial Revascularisation in Coronary Artery Surgery on Angiographic and Clinical Outcomes: the TA Trial

Melbourne Health0 个研究点目标入组 1,000 人开始时间: 2023年8月11日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participating institutions within Australia. Primary isolated adult CABG patients with multivessel coronary disease requiring at least two grafts.

排除标准

  • Previous cardiac surgery involving sternotomy
  • Emergency operation
  • Preoperative myocardial infarction within 48 hours
  • Planned hybrid revascularisation
  • Preoperative severe end-organ dysfunction (Troponin I > 20,000 within five days of surgery
  • Ejection fraction less than or equal to 20%
  • Current inotrope or vasoconstrictor requirement
  • Respiratory pressure support or intubation
  • Acute renal failure or renal replacement therapy <4 weeks
  • Cerebrovascular event of any kind <6 weeks before surgery
  • Cancer or any comorbidity that reduces life expectancy to less than five years
  • Planned concomitant procedure (including coronary endarterectomy and excepting for left atrial appendage occlusion or epicardial pacemaker lead placement)
  • Inability to participate in postoperative follow-up or CTCA including allergy to radiology contrast medium will be excluded

研究者

相似试验